Market News AIOpen the app

LSTA stock news · Lisata Therapeutics, Inc.

Stories about Lisata Therapeutics, Inc. (LSTA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LSTA

Follow Lisata Therapeutics, Inc. (LSTA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LSTA
Free on the App Store and Google Play, or on the web.
  1. Oct 14, 2026, 4:30 PM ET · Market

    Lisata Therapeutics, Inc. announced changes in its leadership, adding Jeffrey Farrow to the Board of Directors.

    Good for LSTA

    Lisata added an experienced biopharma finance executive to its board and audit committee. His background may strengthen oversight, a modest positive for the company.

  2. Sep 17, 2026, 1:15 PM ET · Market

    On Thursday, 12 health care stocks changed a lot, with Aethlon Medical jumping 330.8% and Longeveron dropping 57.3%.

    Neutral

    Lisata's shares climbed in the report, yet only the price change is noted and no business detail is provided, so the story does not change the view.

  3. Sep 17, 2026, 9:32 AM ET · Deal

    Lisata Therapeutics, Inc. has signed a big deal to merge with Marea Therapeutics.

    Bad for LSTA

    Lisata closed a merger that leaves its pre-deal shareholders with about 3.9% ownership; I view this as bearish for LSTA.